Antagonists of lysophosphatidic acid receptors

Details for Australian Patent Application No. 2009333275 (hide)

Owner Amira Pharmaceuticals, Inc.

Inventors Wang, Bowei; Hutchinson, John Howard; Seiders, Thomas Jon; Arruda, Jeannie M.; Roppe, Jeffrey Roger.; Parr, Timothy

Agent Spruson & Ferguson

Pub. Number AU-B-2009333275

PCT Pub. Number WO2010/077883

Priority 61/122,568 15.12.08 US

Filing date 15 December 2009

Wipo publication date 8 July 2010

Acceptance publication date 4 October 2012

International Classifications

C07D 261/06 Heterocyclic compounds having nitrogen and oxygen as the only ring hetero atoms

A61K 31/553 - having at least one nitrogen and at least one oxygen as ring hetero atoms, e.g. loxapine, staurosporine

A61P 11/06 Drugs for disorders of the respiratory system

A61P 13/12 Drugs for disorders of the urinary system

C07D 261/14 Heterocyclic compounds having nitrogen and oxygen as the only ring hetero atoms

Event Publications

2 June 2011 PCT application entered the National Phase

  PCT publication WO2010/077883 Priority application(s): WO2010/077883

4 October 2012 Application Accepted

  Published as AU-B-2009333275

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009333287-Water desalination plant and system for the production of pure water and salt

2009333263-Floor finish applicator